JAPAN AS REPRESENTED BY DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES;Medical & Biological Laboratories Co., Ltd.;Toray Industries, Inc.
发明人:
申请号:
EP15764290.1
公开号:
EP3121273A4
申请日:
2015.03.20
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The present invention provides an anti-hepatitis C virus E2 protein antibody or antigen-binding antibody fragment thereof having infection inhibiting activity against hepatitis C virus (HCV). The present invention further provides an anti-hepatitis C virus E2 protein antibody or antigen-binding antibody fragment thereof comprising a certain variable region, which have infection inhibiting activity against hepatitis C virus (HCV) and exhibits an escape mutant emergence suppressive property.